Company Profile
Kaikai Technology Co., Ltd. is a leading chemical company specializing in the development, production, and marketing of various products, including pharmaceuticals, intermediates, and specialty chemicals. Founded in 1993 and headquartered in Nanjing, Jiangsu, China, the company boasts a robust infrastructure comprising research and development laboratories, manufacturing facilities, and quality control centers. Operating in accordance with stringent environmental and safety standards, Kaikai Technology Co., Ltd. places a strong emphasis on sustainability.
The company's products are widely recognized for their exceptional quality, purity, and effectiveness. They find applications across industries such as pharmaceuticals, chemicals, and biotechnology. In addition to catering to the domestic market, Kaikai Technology Co., Ltd. exports its products to numerous countries worldwide.
Kaikai Technology Co., Ltd.'s success can be attributed to its focus on innovation, quality, and customer service. Its team of experienced scientists and engineers continuously develop new products while enhancing existing ones. The company's commitment to sustainability and customer satisfaction has played a pivotal role in its growth and reputation.
VIEW MORE VIEW LESS
Product List
| Product Name | Synonyms | CAS No. | Grate/Content | Operate |
|---|---|---|---|---|
1-Methyl-5-amino-1H-benzimidazole-2-butanoic acid ethyl ester |
5-AMINO-1-METHYL-1H-BENZIMIDAZOLE-2-BUTANOIC ACID ETHYL ESTER;Ethyl-4-(5-aMino-1-Methy-1H-benzo[d] iMidazol-2-yl)butanoate;1-Methyl-5-amino-1H-benzimidazole-2-butanoic acid ethyl ester;4-(5-Amino-1-methyl-1H-benzoimidazol-2-yl)-butyric acidethylester;5-amino-1-methyl-2-Benzimidazolebutyric acid ethyl ester;5-AMino-1-Methyl-;4-[5-AMino-1-MethylbenziMidazol-2-yl]butanoic acid ethyl ester;1-Methyl-5-aMino-1H-benziMidazole-2-butanoic acid ethyl este |
3543-73-5 | Inquiry | |
5-[Bis(2-hydroxyethyl)amino]-1-methyl-1H-benzimidazole-2-butanoic acid ethyl ester |
Ethyl-4-(5-(bis(2-hydroxyethyl)aMino)-1-Methyl-1H-benzo[d]iMidazol-2-yl)butanoate;5-[Bis(2-hydroxyethyl)aMino]-1-Methyl-2-benziMidazolebutyric Acid Ethyl Ester;4-[5-[Bis(2-hydroxyethyl)aMino]-1-MethylbenziMidazol-2-yl]butanoic acid ethyl ester;ethyl 4-{5-[bis(2-hydroxyethyl)aMino]-1-Methyl-1H-1,3-benzodiazol-2-yl}butanoate;Bendamustine Related Impurity 1;1H-Benzimidazole-2-butanoicacid, 5-[bis(2-hydroxyethyl)amino]-1-methyl-, ethyl ester;5-[Bis(2-hydroxyethyl)amino]-1-methyl-1H-benzimidazole-2-butanoic acid ethyl ester;4-{5-[Bis-(2-hydroxy-ethyl)-amino]-1-methyl-1H-benzoimidazol-2-yl}-butyric acidethylester |
3543-74-6 | Inquiry | |
Agomelatine |
Acetamide,N-[2-(7-methoxy-1-naphthalenyl)ethyl]-;N-[2-(7-Methoxy-1-naphthalenyl)ethyl]acetamide;S 20098;N-[2-(7-Methoxy-1-naphthyl)ethyl]acetamide;Agomelatine;Valdoxan;N-[2-(7-Methoxynaphthalen-1-yl)ethyl]acetamide;AGO 178;Thymanax |
138112-76-2 | Inquiry | |
Bendamustine hydrochloride |
1H-Benzimidazole-2-butanoic acid,5-[bis(2-chloroethyl)amino]-1-methyl-,hydrochloride (1:1);2-Benzimidazolebutyric acid,5-[bis(2-chloroethyl)amino]-1-methyl-,monohydrochloride;1H-Benzimidazole-2-butanoic acid,5-[bis(2-chloroethyl)amino]-1-methyl-,monohydrochloride;IMET 3393;Cytostasan;ZIMET 33/93;Bendamustin hydrochloride;Bendamustine hydrochloride;Ribomustin;SDX 105;Treanda;Bendit;Purplz |
3543-75-7 | Inquiry | |
Butoconazole nitrate |
1H-Imidazole,1-[4-(4-chlorophenyl)-2-[(2,6-dichlorophenyl)thio]butyl]-,nitrate (1:1);1H-Imidazole,1-[4-(4-chlorophenyl)-2-[(2,6-dichlorophenyl)thio]butyl]-,(±)-,mononitrate;1H-Imidazole,1-[4-(4-chlorophenyl)-2-[(2,6-dichlorophenyl)thio]butyl]-,mononitrate;Butoconazole nitrate;(±)-Butoconazole nitrate;Gynomyk;RS 35887;Femstat;RS 35887-00-10-3;Butaconazole nitrate;67085-14-7;1427453-81-3 |
64872-77-1 | Inquiry | |
Dasatinib |
5-Thiazolecarboxamide,N-(2-chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)-1-piperazinyl]-2-methyl-4-pyrimidinyl]amino]-;N-(2-Chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)-1-piperazinyl]-2-methyl-4-pyrimidinyl]amino]-5-thiazolecarboxamide;BMS 354825;Dasatinib;BMS 35482513;Sprycel;Spyrcel;BMS 345825;KIN 001-5;NSC 759877 |
302962-49-8 | Inquiry | |
Entecavir |
6H-Purin-6-one,2-amino-1,9-dihydro-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl]-;6H-Purin-6-one,2-amino-1,9-dihydro-9-[4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl]-,[1S-(1α,3α,4β)]-;2-Amino-1,9-dihydro-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl]-6H-purin-6-one;BMS 200475;Entecavir;SQ 34676;Baraclude;ETV;31: PN: WO2016077321 SEQID: 31 claimed sequence |
142217-69-4 | Inquiry | |
Erlotinib |
4-Quinazolinamine,N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)-;N-(3-Ethynylphenyl)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine;OSI 744;Erlotinib;NSC 718781;R 1415;4-[(3-Ethynylphenyl)amino]-6,7-bis(2-methoxyethoxy)quinazoline |
183321-74-6 | Inquiry | |
Erlotinib hydrochloride |
4-Quinazolinamine,N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)-,hydrochloride (1:1);4-Quinazolinamine,N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)-,monohydrochloride;CP 358774;OSI 774;Tarceva;6,7-Bis(2-methoxyethoxy)-4-(3-ethynylanilino)quinazoline hydrochloride;[6,7-Bis(2-methoxyethoxy)quinazolin-4-yl]-(3-ethynylphenyl)amine hydrochloride;Erlotinib hydrochloride |
183319-69-9 | Inquiry | |
Fasudil |
Isoquinoline,5-[(hexahydro-1H-1,4-diazepin-1-yl)sulfonyl]-;1H-1,4-Diazepine,hexahydro-1-(5-isoquinolinylsulfonyl)-;5-[(Hexahydro-1H-1,4-diazepin-1-yl)sulfonyl]isoquinoline;HA 1077;1-(5-Isoquinolinesulfonyl)homopiperazine;AT 877;Fasudil;Hexahydro-1-(5-isoquinolinesulfonyl)-1H-1,4-diazepine |
103745-39-7 | Inquiry | |
Fasudil hydrochloride |
Isoquinoline,5-[(hexahydro-1H-1,4-diazepin-1-yl)sulfonyl]-,hydrochloride (1:1);1H-1,4-Diazepine,hexahydro-1-(5-isoquinolinylsulfonyl)-,monohydrochloride;1-(5-Isoquinolinesulfonyl)homopiperazine hydrochloride;Eril;Fasudil hydrochloride |
105628-07-7 | Inquiry | |
Fenticonazole nitrate |
1H-Imidazole,1-[2-(2,4-dichlorophenyl)-2-[[4-(phenylthio)phenyl]methoxy]ethyl]-,nitrate (1:1);1H-Imidazole,1-[2-(2,4-dichlorophenyl)-2-[[4-(phenylthio)phenyl]methoxy]ethyl]-,mononitrate;Feniconazole nitrate;REC 15-1476;Fentiderm;Fenticonazole nitrate;Falvin |
73151-29-8 | Inquiry | |
Fludarabine |
9H-Purin-6-amine,9-β-D-arabinofuranosyl-2-fluoro-;Adenine,9-β-D-arabinofuranosyl-2-fluoro-;9-β-D-Arabinofuranosyl-2-fluoro-9H-purin-6-amine;9-β-D-Arabinofuranosyl-2-fluoroadenine;2-Fluoro-9-β-D-arabinofuranosyladenine;9-β-D-Arabinosyl-2-fluoroadenine;NSC 118218;NSC 118218H;F-ara-A;Fludarabine;2-Fluoroadenine arabinoside;2-Fluoro Ara-A;2F-Ara-A |
21679-14-1 | Inquiry | |
Gefitinib |
4-Quinazolinamine,N-(3-chloro-4-fluorophenyl)-7-methoxy-6-[3-(4-morpholinyl)propoxy]-;N-(3-Chloro-4-fluorophenyl)-7-methoxy-6-[3-(4-morpholinyl)propoxy]-4-quinazolinamine;ZD 1839;Iressa;Gefitinib;4-(3′-Chloro-4′-fluoroanilino)-7-methoxy-6-(3-morpholinopropoxy)quinazoline;(3-Chloro-4-fluorophenyl)[7-methoxy-6-[3-(morpholin-4-yl)propoxy]quinazolin-4-yl]amine;4-(3-Chloro-4-fluorophenylamino)-7-methoxy-6-[3-(4-morpholinyl)propoxy]quinazoline;ZD1839;Gefonib;N-(3-Chloro-4-fluorophenyl)-7-methoxy-6-(3-morpholinopropoxy)quinazolin-4-amine |
184475-35-2 | Inquiry | |
Imatinib mesylate |
Benzamide,4-[(4-methyl-1-piperazinyl)methyl]-N-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]-,methanesulfonate (1:1);Benzamide,4-[(4-methyl-1-piperazinyl)methyl]-N-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]-,monomethanesulfonate;Imatinib mesilate;Imatinib mesylate;CGP 57148B;STI 571;Glivec;Gleevac;Gleevec;1-Methyl-4-(4-((4-methyl-3-((4-(pyridin-3-yl)pyrimidin-2-yl)amino)phenyl)carbamoyl)benzyl)piperazine methanesulfonate;Mitinab;ST 571 |
220127-57-1 | Inquiry | |
Lacosamide |
Propanamide,2-(acetylamino)-3-methoxy-N-(phenylmethyl)-,(2R)-;Propanamide,2-(acetylamino)-3-methoxy-N-(phenylmethyl)-,(R)-;(2R)-2-(Acetylamino)-3-methoxy-N-(phenylmethyl)propanamide;Erlosamide;SPM 927;Lacosamide;ADD 243037;Harkoseride;Vimpat;(2R)-2-Acetamido-N-benzyl-3-methoxypropanamide;(R)-2-Acetamido-N-benzyl-3-methoxypropionamide;Lacoset 50;Lacoset;Lacosamide UCB |
175481-36-4 | Inquiry | |
Lenalidomide |
2,6-Piperidinedione,3-(4-amino-1,3-dihydro-1-oxo-2H-isoindol-2-yl)-;3-(4-Amino-1,3-dihydro-1-oxo-2H-isoindol-2-yl)-2,6-piperidinedione;3-(4-Amino-1-oxoisoindolin-2-yl)piperidine-2,6-dione;Revimid;CC 5013;CDC 501;Lenalidomide;Revlimid;1-Oxo-4-amino-2-(2,6-dioxopiperidin-3-yl)isoindole;3-(4-Amino-1-oxoisoindolin-2-yl)piperidin-2,6-dione;ENMD 0997;IMiD 3;revlMiD;346670-73-3;443912-14-9;824975-68-0 |
191732-72-6 | Inquiry | |
Pixantrone dimaleate |
Benz[g]isoquinoline-5,10-dione,6,9-bis[(2-aminoethyl)amino]-,(2Z)-2-butenedioate (1:2);Benz[g]isoquinoline-5,10-dione,6,9-bis[(2-aminoethyl)amino]-,(Z)-2-butenedioate (1:2);BBR 2778;Pixantrone maleate;Pixantrone dimaleate;Pixuvri |
144675-97-8 | Inquiry | |
Prasugrel |
Ethanone,2-[2-(acetyloxy)-6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl]-1-cyclopropyl-2-(2-fluorophenyl)-;Thieno[3,2-c]pyridine,ethanone deriv.;2-[2-(Acetyloxy)-6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl]-1-cyclopropyl-2-(2-fluorophenyl)ethanone;CS 747;Prasugrel;2-Acetoxy-5-(α-cyclopropylcarbonyl-2-fluorobenzyl)-4,5,6,7-tetrahydrothieno[3,2-c]pyridine;LY 640315;Effient free base;2-Acetoxy-5-(α-cyclopropylcarbonyl-2-fluorobenzyl)-4,5,6,7-tetrahydrothieno-[3,2-c]pyridine;[5-[2-Cyclopropyl-1-(2-fluorophenyl)-2-oxoethyl]-6,7-dihydro-4H-thieno[3,2-c]pyridin-2-yl] acetate |
150322-43-3 | Inquiry | |
Sitagliptin phosphate |
1-Butanone,3-amino-1-[5,6-dihydro-3-(trifluoromethyl)-1,2,4-triazolo[4,3-a]pyrazin-7(8H)-yl]-4-(2,4,5-trifluorophenyl)-,(3R)-,phosphate (1:1);1,2,4-Triazolo[4,3-a]pyrazine,7-[(3R)-3-amino-1-oxo-4-(2,4,5-trifluorophenyl)butyl]-5,6,7,8-tetrahydro-3-(trifluoromethyl)-,phosphate (1:1);MK 0431;MK 431;Sitagliptin phosphate;Januvia;Glactiv;790712-60-6 |
654671-78-0 | Inquiry |
CONTACT INFORMATION
Sign In for Details